Education
About Us
Working with TipRanks
Follow Us
Thomas Malley Insider Profile
4 Followers
Thomas Malley, Director at Puma Biotechnology, holds 84.51K shares in Kiniksa Pharmaceuticals (Ticker: KNSA), holds 139.56K shares in Kura Oncology (Ticker: KURA), holds 76.70K shares in BeOne Medicines (Ticker: ONC).
Profitable Transactions
2 out of 5 Profitable Transactions
Average Return
+24.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Thomas Malley holds in companies
Most Profitable Insider Trade
The most profitable trade made by Thomas Malley
Thomas Malley's Trading History
Puma Biotechnology
Oct 25, 2012
Director
Informative Buy
160.00K
$821.89K
BeOne Medicines
Jun 20, 2023
Director
Uninformative Buy
―
$24.06M
Kura Oncology
Jun 21, 2023
Director
Informative Buy
575.00K
$1.07M
Kiniksa Pharmaceuticals
Aug 14, 2025
Director
Uninformative Buy
1.82M
$2.85M
Tempest Therapeutics
Jul 05, 2017
Director
Uninformative Buy
―
$1.26M
Synageva
Jun 23, 2015
―
Uninformative Sell
―
―
List of latest transactions for each holding click on a transaction to see Thomas Malley's performance on stock
You May Also Like
Thomas Malley insider profile FAQ
What is the percentage of profitable transactions made by Thomas Malley?
The percentage of profitable transactions made by Thomas Malley is 40%.
What is the average return per transaction made by Thomas Malley?
The average return per transaction made by Thomas Malley is 24.70%.
What stocks does Thomas Malley hold?
Thomas Malley holds: PBYI, ONC, KURA, KNSA, TPST, GEVA stocks.
What was Thomas Malley’s latest transaction?
Thomas Malley latest transaction was an Uninformative Buy of $1.82M.
What was Thomas Malley's most profitable transaction?
Thomas Malley’s most profitable transaction was an Informative Buy of ONC stock on November 28, 2016. The return on the trade was 182.00%.
What is Thomas Malley's role in Puma Biotechnology?
Thomas Malley's role in Puma Biotechnology is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.